TASK Applied Science performs clinical trials in tuberculosis(TB) in Cape Town, South Africa. The high incidence of tuberculosis in our region illustrates the great need for better diagnostic tests and more effective treatments for TB. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis. Task Applied Science (TASK) was
Institut Pasteur Korea is conceptualized around a virtual “genome to drugs” pipeline. The goal of IPK Korea is to actively implement post-genomic approaches into accelerated drug discovery. Accordingly, IP-Korea is situated at the very fault line between basic research and application. Expertise related to their role in the project: The Biology of Intracellular Pathogens group
The Institute is responsible for surveillance and coordination of National program against tuberculosis in St. Petersburg, Northwest and Northern Russia (17 regions), and has a wide experience in implementation of its results into public health by means of preparation of guiding documents and manuals. Expertise related to their role in the project: The Laboratory of
The École Polytechnique Fédérale de Lausanne is one of two polytechnical universities in Switzerland. With more than 250 laboratories and research groups on campus, EPFL is one of Europe’s most innovative and productive technology institutes. Expertise related to their role in the project: Prof. McKinney and Dr. Dhar lead one of the eight research groups
The Laboratoire de Recherche Moléculaire sur les Antibitiotiques (LRMA; project name: Structures Bactériennes Impliquées dans la Modulation de la Résistance aux Antibiotiques) has functioned as an INSERM unit (U655) that is now integrated as team 12 of the Centre de Recherche des Cordeliers (CRC); UMR S 872; INSERM; Université Pierre et Marie Curie; Université Paris
Cellzome is a pioneer in the development and advancement of proteomics technologies in drug discovery. The company is applying its pathway mapping technology to the analysis of protein-protein interaction networks underlying disease pathways. Cellzome intends to apply its chemical proteomics technology to identify the affinity interactions between active lead compounds and the proteome. Key Personnel
Nanologica AB is the first company commercializing mesoporous nanoparticles for applications in the pharmaceutical and biotechnology industries. Nanologica will be responsible for the synthesis and functionalisation of mesoporous nanoparticles. Key Personnel Alfonso Garcia-Bennett, Krim Talia
The Institute was created in 1923 and has gained a leadership position among epidemiological institutes in Russia oriented to the public health applications of the biomedical sciences. Expertise related to their role in the project: One of main subjects of the Insitute´s research activities in 1997-2009 is directly related to the proposed project: molecular epidemiology
The TB Alliance is a not-for-profit product development partnership accelerating the discovery and development of new TB drugs and regimens that will shorten treatment, be effective against susceptible and resistant strains, be compatible with antiretroviral therapies, and improve treatment of latent infection. The TB Alliance is committed to ensuring that approved new regimens are affordable,
The Institut de Recherche Thérapeutique, INSERM U892, is mainly devoted to Immunological researches with half of the teams being involved in Infectious Diseases projects. The Institute is very well-equiped with NSB2 facilities and free access to the hospital NSB3 laboratory which is completely dedicated to mycobacterial identification and experimental studies. Expertise related to their role
The University of Ljubljana, an institution with more than 56.000 undergraduate and post-graduate students, ranks among the biggest universities in the world scale. A total of 26 faculties employ approx. 3500 teaching and research staff, assisted by nearly 900 technical and administrative staff.
The University of Birmingham has participated in over 100 FP6 Programmes (co-ordinating 2 IPs, 5 STREPs and one Marie Curie Excellence Grant) and, up to date, 32 FP7 Programmes (co-ordinating 6 collaborative projects, 1 ERC starting grant, 1 Marie Curie ITN and 3 Fellowships).